文献速递肝病

纵向饮酒模式对美国退伍军人脂肪性肝病患者长期肝硬化风险的影响

Impact of Longitudinal Alcohol Use Patterns on Long-Term Risk of Cirrhosis Among US Veterans With Steatotic Liver Disease.
PubMed 文献 · Gastroenterology · 2024-02-29

研究纳入2010年1月至2022年12月美国退伍军人脂肪性肝病患者1,156,189例,按AUDIT-C评分分为无饮酒、低风险饮酒和高风险饮酒。高风险饮酒者肝硬化发生率较无饮酒者高43%;基线高风险饮酒者随访中减少饮酒,肝硬化长期风险降低39%(HR 0.61,95%CI 0.45-0.83,P<.01)。

要点

  • 脂肪性肝病退伍军人中约九分之一(11.2%)存在高风险饮酒。
  • 高风险饮酒者肝硬化发生率较无饮酒者高43%。
  • 基线高风险饮酒者随访中减少饮酒,肝硬化风险降低39%(HR 0.61)。

核心结论

  • 脂肪性肝病退伍军人中约九分之一报告合并高风险饮酒,其肝硬化风险较无饮酒者高43%。
  • 减少饮酒可降低肝硬化风险,强调及时评估饮酒并早期干预高风险饮酒的重要性。

研究设计与样本

  • 研究为美国退伍军人脂肪性肝病患者的纵向队列分析,纳入时间为2010年1月至2022年12月。
  • 共识别1,156,189例脂肪性肝病退伍军人,其中54.2%无饮酒、34.6%低风险饮酒、11.2%高风险饮酒。
  • 饮酒评估采用记录的AUDIT-C评分:无饮酒为AUDIT-C=0,低风险饮酒为女性AUDIT-C 1-2分和男性1-3分,高风险饮酒为女性AUDIT-C≥3分和男性≥4分。
  • 肝硬化发生率采用竞争风险Nelson-Aalen方法评估,并采用校正多变量回归模型评估基线饮酒及随访期间饮酒变化与肝硬化风险的关系。

主要发现

  • 高风险饮酒的脂肪性肝病患者肝硬化发生率较无饮酒者高43%。
  • 与基线高风险饮酒且随访中饮酒无变化的患者相比,随访中减少饮酒者肝硬化长期风险降低39%(HR 0.61,95%CI 0.45-0.83,P<.01)。

关键数值与推荐

  • 无饮酒定义为AUDIT-C=0分。
  • 低风险饮酒定义为女性AUDIT-C 1-2分、男性1-3分。
  • 高风险饮酒定义为女性AUDIT-C≥3分、男性≥4分。
  • 基线高风险饮酒且随访中减少饮酒者肝硬化风险HR 0.61(95%CI 0.45-0.83,P<.01)。

临床怎么用

  • 原文结论强调及时评估饮酒并早期干预高风险饮酒在脂肪性肝病中的重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Conflicting data exist on the impact of alcohol use on risk of liver disease progression in patients with steatotic liver disease. We aimed to evaluate the effect of longitudinal alcohol use on risk of cirrhosis among veterans with steatotic liver disease. METHODS: US veterans with steatotic liver disease were identified from January 2010 through December 2022. Alcohol use was assessed using documented Alcohol Use Disorders Identification Test-Concise (AUDIT-C) scores and categorized as no alcohol (AUDIT-C = 0), low-risk alcohol use (AUDIT-C 1-2 for women and 1-3 for men), and high-risk alcohol (AUDIT-C ≥ 3 for women and ≥ 4 for men). Incidence of cirrhosis was evaluated with competing risks Nelson-Aalen methods. Adjusted multivariable regression models evaluated risks of cirrhosis associated with baseline alcohol use and changes in alcohol use during follow-up. RESULTS: There were 1,156,189 veterans with steatotic liver disease identified (54.2% no alcohol, 34.6% low-risk alcohol, and 11.2% high-risk alcohol). Veterans with steatotic liver disease and high-risk alcohol have a 43% higher incidence of cirrhosis compared with patients reporting no alcohol use. Compared with patients with baseline high-risk alcohol who reported no change in alcohol use, those who decreased their alcohol use during follow-up experienced a 39% reduction in long-term risk of cirrhosis (hazard ratio, 0.61; 95% CI, 0.45-0.83; P < .01). CONCLUSIONS: One in 9 veterans with steatotic liver disease report concurrent high-risk alcohol use, which is associated with 43% greater risk of cirrhosis compared with no alcohol use. However, reducing alcohol use lowers risk of cirrhosis, emphasizing the importance of timely alcohol use assessment and early interventions to address high-risk alcohol use in steatotic liver disease.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Wong RJ, Yang Z, Cheung R, et al. Impact of Longitudinal Alcohol Use Patterns on Long-Term Risk of Cirrhosis Among US Veterans With Steatotic Liver Disease. Gastroenterology. 2024. PMID: 38428619. doi:10.1053/j.gastro.2024.02.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。